/A

Phase 1

• Conditions: Arterial Hypertension; Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]; MedDRA version: 14.1Level: PTClassification code 10015488Term: Essential hypertensionSystem Organ Class: 10047065 - Vascular disorders

• Registration Number: EUCTR2011-003328-11-FR
• Lead Sponsor: Servier International / Les Laboratoires Servier

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-09-18
• Last Update Posted: 3 July 2017

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 80
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 20

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: ;Secondary Objective: ;Primary end point(s):